Endoplasmic reticulum Ca2+ release causes rieske iron-sulfur protein-mediated mitochondrial ROS generation in pulmonary artery smooth muscle cells by Dong, Dapeng et al.
Washington University School of Medicine 
Digital Commons@Becker 
Open Access Publications 
12-20-2019 
Endoplasmic reticulum Ca2+ release causes rieske iron-sulfur 
protein-mediated mitochondrial ROS generation in pulmonary 






See next page for additional authors 
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs 
Authors 
Dapeng Dong, Qiongyu Hao, Ping Zhang, Tao Wang, Fei Han, Xiaodong Liang, and Zhenghua Fei 
Bioscience Reports (2019) 39 BSR20192414
https://doi.org/10.1042/BSR20192414
*These authors contributed
equally as co-ﬁrst authors and
are listed alphabetically.
#These authors contributed
equally as co-last authors.
Received: 01 August 2019
Revised: 30 October 2019
Accepted: 07 November 2019
Accepted Manuscript online:
11 November 2019
Version of Record published:
04 December 2019
Research Article
Endoplasmic reticulum Ca2+ release causes Rieske
iron–sulfur protein-mediated mitochondrial ROS
generation in pulmonary artery smooth muscle cells
Dapeng Dong1,*, Qiongyu Hao2,3,*, Ping Zhang4, Tao Wang5, Fei Han6,7, Xiaodong Liang8,# and Zhenghua Fei4,#
1Department of Respiratory and Critical Care Medicine, The First Afﬁliated Hospital of Wenzhou Medical University, Wenzhou 325000, China; 2Division of Cancer Research and
Training, Department of Internal Medicine, Charles Drew University of Medicine and Science, Los Angeles, CA 90059, U.S.A.; 3David Geffen UCLA School of Medicine and UCLA
Jonsson Comprehensive Cancer Center, Los Angeles, CA 90095, U.S.A.; 4Radiation and Medical Oncology Department, The 1st Afﬁliated Hospital of Wenzhou Medical University,
Wenzhou 325000, China; 5The Key Laboratory of Urinary Tract Tumors and Calculi, Department of Urology Surgery, The First Afﬁliated Hospital of Xiamen University, Xiamen
361003, China; 6Division of Radiological Sciences, Washington University School of Medicine in Saint Louis, MO 63110, U.S.A.; 7Department of Pathology, Tongji Hospital, Tongji
University School of Medicine, Shanghai 200065, China; 8Department of Pathology, Yancheng Hospital Afﬁliated Southeast University, Yancheng, Jiangsu 224000, China
Correspondence: Xiaodong Liang (75235249@qq.com) or Zhenghua Fei (feizhenghua@wzhospital.cn)
Mitochondrial reactive oxygen species (ROS) cause Ca2+ release from the endoplasmic
reticulum (ER) via ryanodine receptors (RyRs) in pulmonary artery smooth muscle cells
(PASMCs), playing an essential role in hypoxic pulmonary vasoconstriction (HPV). Here
we tested a novel hypothesis that hypoxia-induced RyR-mediated Ca2+ release may, in
turn, promote mitochondrial ROS generation contributing to hypoxic cellular responses in
PASMCs. Our data reveal that application of caffeine to elevate intracellular Ca2+ concentra-
tion ([Ca2+]i) by activating RyRs results in a significant increase in ROS production in cytosol
and mitochondria of PASMCs. Norepinephrine to increase [Ca2+]i due to the opening of
inositol 1,4,5-triphosphate receptors (IP3Rs) produces similar effects. Exogenous Ca2+ sig-
nificantly increases mitochondrial-derived ROS generation as well. Ru360 also inhibits the
hypoxic ROS production. The RyR antagonist tetracaine or RyR2 gene knockout (KO) sup-
presses hypoxia-induced responses as well. Inhibition of mitochondrial Ca2+ uptake with
Ru360 eliminates N- and Ca2+-induced responses. RISP KD abolishes the hypoxia-induced
ROS production in mitochondria of PASMCs. Rieske iron–sulfur protein (RISP) gene knock-
down (KD) blocks caffeine- or NE-induced ROS production. Taken together, these findings
have further demonstrated that ER Ca2+ release causes mitochondrial Ca2+ uptake and
RISP-mediated ROS production; this novel local ER/mitochondrion communication-elicited,
Ca2+-mediated, RISP-dependent ROS production may play a significant role in hypoxic cel-
lular responses in PASMCs.
Introduction
Calcium ions (Ca2+) are one of the most crucial intracellular second messengers, involved in a plethora
of cellular functions including cell survival and death, muscle contraction, regulation of metabolism, and
gene expression [1]. Hypoxia causes strong vasoconstriction in pulmonary arteries, termed hypoxic pul-
monary vasoconstriction (HPV) [1]. This unique response is an important adaptive mechanism for pul-
monary ventilation/perfusionmatching in the lungs, butmay also become a crucial pathological factor for
pulmonary hypertension [2,3]. HPV results from an increase in intracellular Ca2+ concentration [Ca2+]i),
which is mediated by multiple ion channels in PASMCs. A series of studies have revealed that ryanodine
receptors (RyRs), the Ca2+ release channels on the Endoplasmic reticulum (ER), are important for the
hypoxic increase in [Ca2+]i and contraction in PASMCs [4–6]. All three known subtypes of RyRs (RyR1,
RyR2, andRyR3) are involved in hypoxic Ca2+ and contractile responses in PASMCs.However, RyR2 is the
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most valuable player [7–9]. The hypoxic increase in [Ca2+]i in PASMCs has been thought to be attributed to the en-
hanced production of intracellular reactive oxygen species (ROS) due to their specific effects on ion channels [10–13].
Mitochondria-derived ROS levels are regulated by intracellular Ca2+ levels. Indeed, ROS increase when mitochon-
dria are exposed to high [Ca2+] and [Na+] [14,15]. The specific communication between mitochondrial ROS and
RyR2-mediated Ca2+ release serves as an essential mechanism for hypoxic cellular responses in PASMCs. Notably,
mitochondria are a primary source of the hypoxic production of intracellular ROS, which increases the activity of
protein kinase C and NADPH oxidase, leading to further ROS production, i.e. ROS-induced ROS production (RIRP)
in PASMCs [4,16–19]. The hypoxia-inducedmitochondrial ROS predominantly produce at the complex III, in which
Rieske iron–sulfur protein (RISP) acts as a dispensable molecule [20–22]. Rieske proteins are iron–sulfur protein
(ISP) components of cytochrome bc1 complexes and cytochrome b6f complexes and responsible for electron transfer
in some biological systems [23]. It is a unique [2Fe-2S] cluster in that one of the two Fe atoms is coordinated by two
histidine residues rather than two cysteine residues [24].
Considering all the aforementioned descriptions, together with the fact that Ca2+ signaling is central to mitochon-
drial functions, possibly includingROS generation, in cardiacmyocytes [25], we have proposed an exciting hypothesis
that the hypoxia-induced, RyR2-mediated increase in [Ca2+]i may promote mitochondrial ROS production, which
provides a positive feedback revenue for the hypoxic ROS production, thereby contributing to attendant Ca2+ and
contractile responses in PASMCs. To test our novel hypothesis, we first sought to determine whether direct Ca2+ ad-
dition could increase ROS production in isolated mitochondria from PASMCs. RyR-mediated Ca2+ release plays an
important role in cellular responses in PASMCs, thus, we next examined whether ROS production was augmented as
well in isolated mitochondria from PASMCs following application of the classic RyR agonist caffeine to induce Ca2+
release from the ER. With the intention of defining a potential mechanism for the enhanced mitochondrial-derived
ROS production in PASMCs, as a result of RyR-dependent Ca2+ release by caffeine, we planned to investigate the
effect of pharmacological inhibition of mitochondrial Ca2+ uptake with Ru360 and genetic suppression of RISP in
mitochondrial complex III using lentiviral RISP shRNAs. To extend these studies, we conducted a set of experiments
to assess whether inhibition ofmitochondrial Ca2+ uptake with Ru360 and prevention of RyR2-mediated Ca2+ release
with its antagonist tetracaine and gene knockout were able to block the hypoxia-induced mitochondrial derived ROS
production in PASMCs.
Materials and methods
Preparation of PAs and PASMCs
Resistance (third and smaller intralobar) PAs free of endothelium and connective tissues were dissected from male
C57/B6 mice at 2 months old. PASMCs were isolated from the dissected PAs using the two-step enzymatic digestion
method, in which the arteries were digested with papain and then collagenase in physiological saline solution (PSS).
The harvested PASMCswere cultured inmodified Dulbecco’s minimal essential medium (DMEM) for three passages
and used in experiments.
PAs and PASMCs from smooth muscle-conditional RyR2 gene knockout (KO) mice on C57/B6 background were
obtained as the same as described above. RyR2 KO mice were generated by crossbreeding RyR2flox/flox mice with
smooth muscle-specific myosin heavy chain Cre recombinase mice. The KO mice were genotyped by polymerase
chain reaction analysis of tail tip DNAs. Western blot analysis revealed that these mice showed the absence of RyR2
expression in PAs.
Detection of ROS production
ROS production in PASMCs was measured using chloromethyldihydrodichlorofluorescein diacetate
(CM-H2DCF/DA) assay by ROS Detection Cell-Based Assay Kit (Item# 601520, CAYMAN CHEMICAL) ac-
cording to the manufacturer’s protocol. Briefly, PASMCs were seeded in a black tissue culture treated 96-well plate
at a desired concentration. Pyocyanin and N-acetyl Cysteine were designated as positive and negative control,
respectively. Culture media were aspirated off and 150 μl of Cell-Based Assay Buffer were added in the well.
Cell-Based Assay Buffer were aspirated off and a small amount of liquid were left in the well. About 130 μl of ROS
Staining Buffer were added in each well. About 10 μl of N-acetyl Cysteine were added as negative control. Cell were
covered and incubated at 37◦C, protected from light. About 10 μl of Pyocyanin Working Reagent were added after
30-min incubation as positive control, and incubated for an additional hour at 37◦C, protected from light. Staining
buffer were aspirated carefully and 100 μl of Cell-Based Assay Buffer was added in the well. The assay plate were
placed in the GloMax®-Multi Detection System (Promega), and the fluorescence was measured using an excitation
wavelength between 480 and 500 nm and an emission wavelength between 510 and 550 nm. Mitochondrial ROS
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was measured using Mitochondrial ROS Detection Assay Kit (Item# 701600, CAYMAN CHEMICAL), according to
the manufacturer’s protocol. Different concentrations of buffered Ca2+ or hypoxia were apply to respiration buffer
and ROS was detected at 37◦C using the GloMax®-Multi Detection System. Cytosolic ROS was also assessed using
specific ROS biosensor pHyPer-cyto [26]. Primary cultured PASMCs were transfected with pHyPer-cyto construct.
After transfection for 72 h, caffeine or norepinephrine was added to induce ROS production. HyPer was alternatively
excited at 420 and 500 nm. Emitted fluorescence at 510 nm was measured at 37◦C using the GloMax®-Multi
Detection System.
Lucigenin and Redox Sensor Red CC-1 (Red CC-1) also detected ROS production in PASMCs and mitochon-
dria. Lucigenin (20 μM, Molecular Probes, R-6868) was added to one well of 96-well plate which containing 1.5 ×
105 PASMCs or 10 μg mitochondria sample or 3 μg of complex III protein. Emitted chemiluminescence derived
by lucigenin was detected by GloMax®-Multi Detection System. The initial (maximal) values of lucigenin-derived
chemiluminescencewere normalized to control group. As described previously [27,28], same amount of PASMCs and
mitochondria samples as used in lucigenin assay were loaded at 37◦C for 30 min with Red CC-1 (1 mM, Molecular
Probes, R-14060). Red CC-1 derived fluorescence was measured using a GloMax®-Multi Detection System with an
excitation wavelength of 544 nm and emission wavelength of 612 nm. Intracellular ROS production was determined
by the difference in fluorescence between the wells containing the assay buffer with and without cells. Fluorescent
intensity was normalized to control group.
Intracellular calcium ([Ca2+]i) detection
Intracellular calcium were measured using Calcium Quantification Kit - Red Fluorescence (abcam, cat#: ab112115),
according to the manufacturer’s protocol. Briefly, prepare a calcium standard by diluting the appropriate amount of
the 300 mM Calcium Standard into H2O to produce a calcium concentration ranging from 0 to 3 mM (12 mg/dl).
Add 50μl of serial diluted calcium standard into each well. Add 50μl of assay reactionmixture to each well of calcium
standard, blank control, and test samples to make the total calcium assay volume of 100 μl/well. Incubate the reaction
for 5–30 min at room temperature, protected from light. Monitor the fluorescence intensity with a fluorescence plate
reader at Ex/Em = 540/590 nm.
Intra-mitochondria calcium ([Ca2+]mito) detection with mutant aequorin
Mitochondria targeted calcium sensor pcDNA3.1+/mit-2mutAEQ (Asp119 to Ala, Asn28 to Leu points mutations
on aequorin) was a gift from Javier Alvarez-Martin (Addgene plasmid # 45539). According to previous report,
pcDNA3.1+/mit-2mutAEQ was purified and transfected to primary cultured mouse PASMCs. After transfection,
PASMCs were incubated for 2 h at room temperature in standard medium [145 mMNaCl, 5 mMKCl, 1 mMMgCl2,
1 mM CaCl2, 10 mM glucose and 10 mM Hepes (pH 7.4)] with 2 μM coelenterazine w (Cat#10110-1, Biotium).
After incubation, PASMCs were treated with different concentrations of caffeine and norepinephrine for 5 min. Lu-
minescence intensities were recorded by luminometer. Luminescence unit was calibrated into Ca2+ concentration by
following previous publications [29].
RISP KD
Lentiviral shRNAs specific for RISPwere used to knockdown its expression in PASMCs. Lentiviruses containing RISP
shRNAs and non-silence shRNAs were purchased from ThermoScientific OpenBiosystems and then packaged using
pCMV-dR8.2 dvpr and pCMV-VSV-G packing vectors. The efficiency of RISP KD was determined using Western
blot analysis.
Hypoxia
To induce hypoxic responses, samples were treated with a normoxic medium that was aerated with a 21% O2, 5%
CO2 and 74% N2 mixture for 10 min and then hypoxic medium gassed with a 1% O2, 5% CO2 and 94% N2 mixture
for 5 min. As a control, samples were treated with normoxic medium alone.
Animal and ethics information
All animal experiments were performed at animal facility of Wenzhou Medical University according to an approved
protocol by the Animal Care and Ethics Committee of WenzhouMedical University. Male C57BL/6 mice bred under
specific pathogen-free conditions were 8–10 weeks old at exposure initiation. All the investigations complied with
the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
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Statistical analysis
Levels of statistical significance were evaluated with data from no less than three independent experiments using one-
or two-way ANOVA with an appropriate post hoc test. The differences between the means of data at P < 0.05 were
considered statistically significant.
Results
Application of caffeine and norepinephrine to elevate [Ca2+]i signiﬁcantly
increase ROS production in PASMCs
Caffeine triggers Ca2+ release by reducing the threshold for luminal Ca2+ activation of RyR2 [30]. Here, we first ex-
amined whether RyR-mediated Ca2+ release might cause ROS generation in PASMCs. Cells were treated with the
classic RyR agonist caffeine (200 μM) for 5 min, ROS generation was remarkably increased in caffeine-treated cells
compared with untreated cells by measuring DCFDA-derived fluorescence intensity (Figure 1A). Norepinephrine,
a major vascular neurotransmitter, can increase [Ca2+]i by largely inducing Ca2+ release from the ER via inositol
1,4,5-trisphosphate receptors (IP3Rs) in vascular SMCs [31]. Accordingly, we sought to test whether treatment with
norepinephrine could also increase ROS production in PASMCs. Similar to caffeine, application of norepinephrine
(20μM) for 5min resulted in an increase in intracellular ROS production in PASMCs (Figure 1A). Representativemi-
croscope images of DCFDA fluorescence were shown in Supplementary Figure S1A. We also observed that exposure
of caffeine or norepinephrine facilitated Ca2+ release in cytosol (Figure 1B). Caffeine- and norepinephrine-induced
ROS generation was also detected by Red CC-1-derived fluorescence intensity and lucigenin emitted chemilumines-
cence (Figure 1C,D). Similar toDCFDAmethod, these results confirmed that caffeine and norepinephrine could elicit
intracellular ROS generation. Simultaneously, we found marked increase in Fluo-3 AM fluorescence of the cytosolic
calcium levels after caffeine or NE treatment as compared with control in PASMCs (Figure 1G). Hypoxia or deoxy-
genated blood causes lower pressure and less vessel resistance in pulmonary arteries. However, in systemic arteries,
i.e. mesentery arteries, transmitting deoxygenated blood leads to vessel constriction and increasing of vessel pressure.
We speculate ER Ca2+ release induced ROS generation may show distinct functional difference between pulmonary
arteries and mesentery arteries. As shown in Figure 1E, caffeine and norepinephrine were not able to induce ROS
generation in cytosol of primary cultured mesentery artery smooth muscle cells (MASMCs); however, they elevated
intracellular Ca2+ concentration (Figure 1F). ROS measurement in MASMCs were also performed by Red CC-1 and
lucigenin (Supplementary Figures S2 and S3).
Inhibition of mitochondrial Ca2+ uptake blocks caffeine-induced ROS
production in PASMCs and Ca2+-evoked ROS generation in mitochondria
of PASMCs
It is known that mitochondria is central sources for intracellular ROS generation in PASMCs [32,33]. To further
prove the role of Ca2+ in mitochondrial ROS production, we investigated the effect of caffeine, norepinephrine
and hypoxia-induced increase in intramitochondria Ca2+ concentration [Ca2+]mito). Mitochondria targeted Ca2+
sensor pcDNA3.1+/mit-2mutAEQ generated luminescence intensity was calibrated with different concentration of
buffered Ca2+ (Supplementary Figure S4). Norepinephrine and caffeine were exposed to pcDNA3.1+/mit-2mutAEQ
transfected PASMCs. Emitted luminescence intensities were calibrated to [Ca2+]mito concentration and quanti-
fied as dose–response curve. As shown in Figure 2A,B, caffeine and norepinephrine can increase [Ca2+]mito in a
dose-dependent manner. We assumed that caffeine- or NE-induced Ca2+ release might cause mitochondrial Ca2+
uptake, and accordingly mediate Ca2+-dependent mitochondrial ROS generation. To test this assumption, PASMCs
were treated with Ru360 (1 μM), which is a mitochondria calcium uniporter (MCU) inhibitor [34], for 5 min, then
exposed to caffeine (200 μM) or NE (20 μM) for 5 min in the presence of Ru360. As shown in Figure 2C,D, treatment
with Ru360 attenuated caffeine- or NE-elicited ROS production in mitochondria. Previous study indicated that cell
stimulation caused local hotspot of Ca2+ transients (20–40 μM), while the Ca2+ transients increase of the rest of cells
is much less (1–2 μM) [35]. Activation of calcium-ion (Ca2+) channels on the plasma membrane and on intracellular
Ca2+ stores, such as the endoplasmic reticulum, generates local transient increases in the cytosolic Ca2+ concentration
that induce Ca2+ uptake by neighboring mitochondria. In order to clarify the effects of Ca2+ on mitochondria ROS
generation, we designed different concentration of buffered Ca2+ to mimic local Ca2+ transient. Freshly isolated mi-
tochondria from PASMCs were incubated with different concentrations of buffered Ca2+. As shown in Figure 2E, 1,
10 and 100 μMCa2+ significantly changedmitochondrial ROS generation detected by DCFDA. In agreement with its
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Figure 1. Elevation of [Ca2+]i by caffeine or norepinephrine increases ROS production in cytosol of PASMCs, but not
MASMCs
(A) PASMCs were treated with caffeine (200 μM) or norepinephrine (20 μM) for 5 min. Intracellular ROS generation was measured
using DCFDA assay. (B) PASMCs were exposed to caffeine (200 μM) or norepinephrine (20 μM) for 5 min, and Ca2+ levels were
then detected using a Ca2+ quantification kit. (C) Red CC-1 and lucigenin (D) assay was used to determine ROS generation in
PASMCs. (E) MASMCs were treated with caffeine (200 μM) or norepinephrine (20 μM) for 5 min. Intracellular ROS generation was
measured using DCFDA assay. (F) MASMCs were exposed to caffeine (200 μM) or norepinephrine (20 μM) for 5 min, and Ca2+
levels were then detected using a Ca2+ quantification kit. Data represent mean +− SEM; n = 6, *P < 0.05; **P < 0.01; ***P < 0.001,
compared with control by two-tails Student’s t test. (G) Fluo3-AM staining of cytosolic Ca2+ ions in PASMCs. PASMCs were treated
with caffeine (200 μM) or norepinephrine (20 μM) for 5 min, then stained with 0.5 μ M Fluo-3-AM in HBSS buffer.
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Figure 2. Caffeine or norepinephrine elevates mitochondrial ROS by mitochondrial Ca2+ inﬂux ([Ca2+]mito)
(A) [Ca2+]mito was determined by mitochondria-targeted double-mutated aequorin (pcDNA3.1+/mit-2mutAEQ), which was de-
scribed in ‘Materials and Methods’ section. Mitochondria Ca2+ uniporter inhibitor Ru360 (1 μM) decreased [Ca2+]mito caused by
caffeine or norepinephrine (B and C); PASMCs were treated with caffeine (200 μM) or norepinephrine (20 μM) (D) for 5 min. Mito-
chondrial ROS generation was measured using a Mitochondrial ROS Detection Assay Kit. (E) Freshly isolated mitochondria from
PASMCs were exposed with different concentrations of Ca2+ in the presence or absence of Ru360 (1 μM); mitochondria ROS were
determined by DCFDA assay. Data were obtained from three separate experiments. *P < 0.05; **P < 0.01; ***P < 0.001 compared
with Ca2+ (0 μM) group. #P<0.05, ##P < 0.01 compared Ca2+ (100 μM) with absence of Ru360 group.
effect on caffeine- or NE- induced responses, treatment with Ru360 blocked Ca2+-evoked ROS generation in isolated
mitochondria (Figure 2E).
Inhibition of RyRs attenuates hypoxic ROS production in PASMCs
RyR-mediated Ca2+ release is essential for the hypoxic increase in [Ca2+]i in PASMC [36,37]. Previous studies have
shown that RyR1, RyR2 and RyR3 all are expressed and mediate acute hypoxic [Ca2+]i and contractile responses in
PASMCs; however, the role of RyR2 dominates over that of RyR1 and RyR3 [38,39]. To explore the role of RyRs in the
hypoxic ROS generation in PASMCs, we treated PASMCs with the RyR antagonist tetracaine (1 μM) for 5 min and
then exposed to hypoxia for 5 min. ROS generation was largely suppressed in PASMCs by treatment with tetracaine
under hypoxic conditions (Figure 3A). We also examined the effect of RyR2 KO on the hypoxic ROS production in
PASMCs. RyR2 KO PASMCs was isolated from RyR2 KO mice. Figure 3C showed no RyR2 protein expression in
RyR2 KO PASMCs. As shown in (Figure 3D), acute hypoxic exposure caused ROS increase in PASMCs, but not in
RyR2 KO PASMCs. Ca2+ release in cytosol by hypoxia treatment were also observed (Figure 3B,E). RyR2 KO also
blocked NE induced mitochondrial ROS increase in PASMCs (Figure 3F).
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Figure 3. Inhibition or genetic deletion of RyR2 blocks hypoxic ROS production in PASMCs
(A) Intracellular ROS production was detected by DCFDA assay in PASMCs treated with RyRs inhibitor tetracaine (1 μM) for 5 min
followed by hypoxia for 5 min. (B) Intracellular Ca2+ levels were then detected using a Ca2+ quantification kit. Data were obtained
from three separate experiments. *P < 0.05; **P < 0.01; ***P < 0.001 compared with normoxic control group, and #P < 0.05; ##P
< 0.01 compared with hypoxic control group. (C) Western blots of RyR2 expression in WT and RyR2 KO PASMCs. (D) PASMCs
from wild-type (WT) and RyR2 KO mice were exposed to normoxia or hypoxia for 5 min. ROS were measured in cells by DCFDA
assay. (E) Intracellular Ca2+ levels were then detected using a Ca2+ quantification kit. Data were obtained from three separate
experiments. **P < 0.01 compared with normoxic WT group, and ##P < 0.01 compared with hypoxic WT group. (F) Mitochondrial
ROS generation upon NE treatment in WT and RyR2 KO PASMCs.
Inhibition of RyRs and mitochondrial Ca2+ uptake block hypoxia-induced
mitochondrial ROS production in PASMCs
Wenext determined ROS production inmitochondria of PASMCs following hypoxia exposure.We assessed the effect
of RyRs on mitochondrial ROS production. The results indicated that mitochondrial ROS generation was increased
by hypoxia treatment (Figure 4A). Inhibition of RyRswith tetracaine or IP3Rwith 2-APB attenuated hypoxia-induced
ROS generation inmitochondria (Figure 4A,C). The hypoxic ROS increase was significantly suppressed inmitochon-
dria fromRyR2 KOPASMCs (Figure 4B). To evaluate mitochondrial ROS generation upon cytosolic [Ca2+]i increase,
PASMCs were treated with Ru360 for 5 min, then hypoxia was introduced for 5 min. As shown in Figure 4D, Ru360
abolished hypoxia-induced ROS generation in mitochondria. The elevation of [Ca2+]mito was significantly inhibited
by Ru360 (Figure 4E). RyR2 overexpression rescued mitochondrial ROS increase in RyR2 KO PASMCs (Figure 4F).
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution









niversity in St Louis user on 04 January 2020
Bioscience Reports (2019) 39 BSR20192414
https://doi.org/10.1042/BSR20192414
Figure 4. Inhibition or genetic deletion of RyR2 blocks hypoxic ROS production in mitochondria of PASMCs
(A) PASMCs were pretreated with tetracaine (1 μM) (C) for 5 min followed by hypoxia for 5 min. Mitochondrial ROS generation
was measured using a Mitochondrial ROS Detection Assay Kit. **P < 0.01 compared with normoxia control group, and ##P <
0.01 compared with hypoxia control group. (B) PASMCs from WT and RyR2 KO mice were exposed to normoxia or hypoxia for
5 min. Mitochondrial ROS were measured by a Mitochondrial ROS Detection Assay Kit. Data were obtained from three separate
experiments. **P < 0.01 compared with control, and #P < 0.05; ##P < 0.01 compared with WT group. (C) WT and RyR2 KO
PASMCs were pretreated with 2-APB (20 μM) for 5 min followed by hypoxia. Mitochondrial ROS generation were measured using a
Mitochondrial ROS Detection Assay Kit. **P < 0.01 compared with normoxia control group, and ##P < 0.01 compared with hypoxia
control group group. (D) Cells were treated with Ru360 (1 μM) for 5 min, then exposed to caffeine (20 mM) for 5 min. mitochondrial
ROS were measured by using a Mitochondrial ROS Detection Assay Kit. **P < 0.01; ***P < 0.001 compared with normoxia control
group, and ##P < 0.01 compared with hypoxia control group. [Ca2+]mito was determined by mitochondria-targeted double-mutated
aequorin (pcDNA3.1+/mit-2mutAEQ). Ru360 (1 μM) decreased hypoxia-caused [Ca2+]mito. (E) RyR2 KO PASMCs were transfected
with RyR2 overexpression plasmids. All groups were treated with hypoxia for 5 min. Mitochondrial ROS generation were measured
using a Mitochondrial ROS Detection Assay Kit. **P < 0.01 compared with WT group, and #P < 0.05 compared with WT RyR2 KO
group.
Rieske iron–sulfur protein gene silencing inhibits caffeine and
hypoxia-induced ROS production in PASMCs and Ca2+-evoked ROS
generation in mitochondria from PASMCs
Studies have shown that RISP is indispensable for the hypoxic ROS generation in PASMCs [40]. To determine the role
of RISP in Ca2+-induced ROS generation, RISP shRNA was retrovirally transduced into PASMCs, data showed RISP
protein expression were largely suppressed compared with non-infected or NS shRNA (Figure 5A). We also demon-
8 © 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 5. RISP gene knockdown blocks hypoxia-, caffeine- or NE- induced ROS production in PASMCs
(A) Western blots of RISP expression in PASMCs uninfected, infected with lentiviral RISP shRNA, and non-silencing (NS) shRNA.
(B) Mitochondrial and Cytosolic ROS (C) were determined after hypoxia treatment. RISP knockdown inhibited hypoxia-induced
ROS increase. Data were obtained from three separate experiments. **P < 0.01 compared with normoxia NS shRNA group, and #P
< 0.05; ##P < 0.01 compared with hypoxia NS shRNA groups. (D) RISP KO PASMCs were transfected with RISP overexpression
plasmids. All groups were treated with hypoxia for 5 min. Mitochondrial ROS generation were measured using a Mitochondrial
ROS Detection Assay Kit. **P < 0.01 compared with WT group, and #P < 0.05 compared with WT RISP KO group. (E) PASMCs
were treated with caffeine (200 μM) (E andF) or NE (20 μM) (G and H) for 5 min in non-infected, infected with non-silencing (NS)
shRNA PASMCs or lentiviral encoding RISP shRNA. Mitochondria and Cytosolic ROS were determined after treatment. Data were
obtained from three separate experiments. ***P < 0.001 compared with non-infected control group, and #P < 0.05; ##P < 0.01
compared with caffeine-treated NS shRNA group.
strated that hypoxia-induced mitochondrial ROS generation was significantly inhibited in RISP-deficient PASMCs
(Figure 5B).Moreover, knockdownRISP also slightly suppressed cytosolic hypoxia-ROS generation (Figure 5C). RISP
overexpression rescuedmitochondrial ROS increase in RISP KO PASMCs (Figure 5D). Caffeine-or NE-evokedmito-
chondrial ROS production was abolished in PASMCs infected with lentiviral RISP shRNAs (Figure 5E,G). However,
Ca2+-induced ROS production in cytosol was slightly attenuated by RISP knockdown (Figure 5F,H).
Discussion
ROS-mediated increase in [Ca2+]i plays an important role in hypoxia-induced pulmonary vasoconstriction, vasore-
modeling and even hypertension [41,42]. Presumably, the talk of Ca2+ signaling to ROS signaling may enhance the
hypoxia-induced ROS production in PASMCs, which provides a positive mechanism to mediate the hypoxic ROS
production and associated cellular responses.
In the present study, we have also found that application of norepinephrine, a major neurotransmitter in vascular
SMCs, to active α-adrenergic receptors and increased [Ca2+]i can result in an increase in ROS generation as well
in PASMCs. It is well known that activation of α-adrenergic receptors induces ER Ca2+ release by opening inositol
1,4.5-triphosphate receptors (IP3Rs). Ca2+ release via IP3Rs may activate adjacent RyRs to induce further ER Ca2+
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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Figure 6. ROS and Calcium crosstalk between endoplasmic reticulum and mitochondria
The ER is a major site of calcium ions (Ca2+) storage within muscle cells. Calcium from ER cisternae is flowing mainly through
calcium release channels as inositol 1,4,5-trisphosphate receptors (IP3R) and ryanodine receptors (RyR). High levels of calcium
stimulate respiratory chain activity leading to higher amounts of reactive oxygen species (ROS) through RISP. ROS can further
target ER-based calcium channels leading to increased release of calcium and further increased ROS levels.
release, i.e., a local Ca2+-induced Ca2+ release (CICR) process, in PASMCs [43,44]. Thus, the role of norepinephrine
in inducing ROS production is likely to be, at least in part, implemented by RyR-dependent Ca2+ release as a result
of local IP3R/RyR interaction-mediated CICR. Another novel finding is that the application of caffeine to activate
RyRs on the ER and then to induce Ca2+ release by the ER can also cause a significant increase ROS production
in isolated PASMCs. Mitochondria are a major source for ROS production in PASMCs, and mitochondrial ROS
is primarily generated at complex III [45–48]. Consistent with these previous reports, the present study has also
shown that Ca2+ release following activation of RyRs with caffeine increases ROS production in mitochondria from
PASMCs. Application of norepinephrine, similar to caffeine, also results in an increase in ROS production as well
in mitochondria from PASMCs. Moreover, by using mitochondria targeted Ca2+ sensor, we successfully measured
and quantified the amount of Ca2+ changes inside the mitochondria induced by different concentrations of caffeine
or norepinephrine. In complement of caffeine- and norepinephrine-induced responses, different concentrations of
exogenous Ca2+ also significantly increase ROS production in isolated mitochondria from PASMCs. These data not
only reveal that Ca2+ release from the ER may cause intracellular ROS production primarily at mitochondrial in
PASMCs, but also further support our novel concept that the ER can locally communicate with closely neighboring
mitochondria in a format of Ca2+-mediated ROS production in PASMCs.
We have surmised that the increased [Ca2+]i may give rise to an increase in mitochondrial Ca2+ uptake, leading
to ROS production in mitochondria. Consistent with our conjecture, treatment with Ru360, a specific mitochon-
drial Ca2+ uptake inhibitor [49], prevents caffeine from inducing ROS production in PASMCs. Likewise, Ru360
also blocks caffeine-induced ROS generation in mitochondria from PASMCs. More interestingly, Ru360 inhibits
10 © 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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hypoxia-induced mitochondrial ROS production. These results reveal that mitochondrial Ca2+ uptake serves as a
critical step for Ca2+-dependent ROS production, thereby playing an important role in hypoxic cellular responses in
PASMCs.
Previous study have demonstrated that RyRs play an important role in hypoxia-induced increase in [Ca2+]i in
PASMCs and pulmonary vasoconstriction in PAs [50–53]. Hypoxia may inhibit voltage-dependent K+ (Kv) channels
and activate store-operated Ca2+ (SOC) channels, leading to Ca2+ and contractile responses in PASMCs; however, the
hypoxic inhibition of Kv channels and activation of SOC channels may be secondary to ER Ca2+ release, presumably
via RyRs [51]. These data reinforce the importance of RyRs in hypoxic cellular responses in PASMCs. As such, we have
assumed that hypoxia-induced, ROS-initiated, RyR-mediated ER Ca2+ release may cause further ROS production in
PASMCs. Indeed, in the present study we have observed that treatment with tetracaine to block RyRs remarkably in-
hibits the hypoxic ROS production in PASMCs. Tetracaine also reduces the hypoxic response in isolatedmitochondria
from PASMCs. All three known RyR subtypes are involved in hypoxic Ca2+ and contractile responses in PASMCs;
however, RyR2 is the most valuable player. In agreement with this notion, we have unveiled that hypoxia causes a
much smaller increase in ROS production in PASMCs from RyR2 KO mice than control (WT) mice. Furthermore,
the hypoxic ROS generation is significantly reduced in mitochondria from RyR2 KO mice. These pharmacological
and genetic findings demonstrate that RyR2 functions as a keymolecule to implement the focal communication from
the ER to mitochondria, leading to Ca2+-dependent ROS production in PASMCs during hypoxic stimulation.
In support, Waypa et al. have also found that RISP gene depletion abolishes hypoxia-induced increase in [Ca2+]i in
pulmonary arteries and right ventricular systolic pressure [22]. In line with the importance role of RISP, in the present
studywe have discovered that RISP knockdown inhibits Ca2+- and caffeine-inducedROS production inmitochondria
from PASMCs. We have also shown that RIPS plays an important role in hypoxia-induced increase in [Ca2+]i in
PASMCs. However, further experiments are needed to determine whether Ca2+ may produce a direct or an indirect
effect on RISP-mediated mitochondrial ROS production in PASMCs.
Mitochondrial ROS are generated in both physiological and pathological conditions. On the one hand, moderate
levels of ROS are involved in cell signaling by affecting the redox state of signaling proteins, Under physiological
conditions, the balance between ROS generation and ROS scavenging is highly controlled [54]. However, on the
other hand, excessive mROS are among the major determinants of toxicity in cells and organisms [55]. Physiological
ROS levels initiate a wide array of cellular responses, ranging from triggering signaling pathways, activation of mito-
chondrial fission and autophagy, adaptation to hypoxic condition, and differentiation to regulation of aging-related
processes [56]. In specific conditions, ROS production is induced in response to a stress and it functions as an in-
termediate signaling to facilitate cellular adaptation [57]. Thus, the study of the crosstalk between calcium and ROS
in pathophysiological conditions might be useful to identify novel therapeutic strategies to cure pathologies char-
acterized by dysregulation of mitochondrial Ca2+ homeostasis. In summary, the present study is the first time to
demonstrate that Ca2+ release from the ER via RyRs or IP3Rs can increase [Ca2+]i, mitochondrial Ca2+ uptake, and
RISP-dependent mitochondrial ROS production (Figure 6). This novel focal communication from the ER to mito-
chondria in the form of Ca2+-induced ROS production may play an important role in the overall hypoxia-induced
mitochondrial RISP-dependent ROS production, thereby contributing to Ca2+ and contractile responses in PASMC.
Highlights
• Agonist-induced ER Ca2+ release increases ROS production in mitochondria of PASMCs.
• Exogenous Ca2+ causes ROS production in isolated mitochondria. RYR2 antagonist or Ryr2 KO, mitochondrial
Ca2+ uptake inhibitor, RISP KD all prevent the hypoxic ROS production.
• ER/mitochondrion communication-elicited, Ca2+-mediated, RISP-dependent ROS productionmay significantly
contribute to hypoxic cellular responses in PASMCs.
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